June 20, 2017
Sponsored by
OmniSeq

Beyond IHC: An RNAseq-based Immune Report Card to Personalize Cancer Immunotherapy

GenomeWebinar

Professor and Chair of the Department of Medicine, Roswell Park Cancer Institute

Assistant Professor, Cell Biology Research, Radiation Oncology, Weill Cornell Medical College

Founder and Chief Scientific Officer, OmniSeq

This webinar will discuss RNA sequencing as an alternative to immunohistochemistry (IHC) in selecting patients for cancer immunotherapy.

 

Recent progress in our understanding of the complex conditions required to activate a therapeutically relevant tumor-targeting immune response revealed several challenges in personalizing cancer immunotherapy. Currently, patient selection for standalone PD-1 checkpoint inhibition relies on the assessment of PD-L1 expression levels by IHC, which does not provide satisfactory stratification.

In this webinar, speakers from Roswell Park Cancer Institute, Weill Cornell Medical College, and OmniSeq will provide an overview on the fundamentals of cancer immunotherapy and will demonstrate that RNAseq offers a superior alternative to IHC for simultaneously measuring multiple immunological markers towards improved patient selection.

The presentations will include several cases of patients treated with checkpoint inhibitors at Roswell Park Cancer Institute.

Sponsored by

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.

May
09
Sponsored by
SeraCare

This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.

May
11
Sponsored by
PerkinElmer

This webinar will provide an overview of an RNA-seq protocol that has been optimized to study small RNA species such as microRNAs.

May
23
Sponsored by
Agilent Technologies

This webinar will discuss a target enrichment workflow for high-confidence detection of variants. 

Jun
20
Sponsored by
OmniSeq

This webinar will discuss RNA sequencing as an alternative to immunohistochemistry (IHC) in selecting patients for cancer immunotherapy.